Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ventyx Biosciences, Inc. - Common Stock (NQ:VTYX)

0.8901 +0.0540 (+6.46%)
Streaming Delayed Price Updated: 10:48 AM EDT, Apr 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,100,070
Open 0.8660
Bid (Size) 0.8810 (10)
Ask (Size) 0.8900 (7)
Prev. Close 0.8361
Today's Range 0.8300 - 0.9409
52wk Range 0.7830 - 5.660
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
VENTYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Ventyx Biosciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Sanofi Injects $27M In Neurology Drug Developer Ventyx Biosciences
Sanofi invests $27 million in Ventyx Biosciences at $3.8243 per share. The investment will fund VTX3232 trials for Parkinson's disease. 
Via Benzinga

Performance

YTD
-58.4%
-58.4%
1 Month
-37.3%
-37.3%
3 Month
-63.2%
-63.2%
6 Month
-58.0%
-58.0%
1 Year
-81.1%
-81.1%

More News

Read More
VTYX Stock Earnings: Ventyx Biosciences Beats EPS for Q2 2024
Via InvestorPlace
Dow Edges Lower; Ventyx Biosciences Shares Plummet
Via Benzinga
Topics Stocks
Exposures US Equities
Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Crude Oil Moves Lower; NLS Pharmaceutics Shares Jump
Via Benzinga
Exposures Fossil Fuels
Ventyx Biosciences' Inflammatory Bowel Disease Candidate Flunks In Mid-Stage Study, Company Looks For Partner To Pursue It Further
Via Benzinga
S&P 500 Edges Lower; J. M. Smucker Shares Surge Following Earnings Beat
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Crude Oil Jumps 2%; Lululemon Posts Upbeat Earnings
Via Benzinga
Exposures Fossil Fuels
Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
VENTYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Ventyx Biosciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
VTYX Stock Earnings: Ventyx Biosciences Beats EPS for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
VTYX DEADLINE TODAY: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action - VTYX
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
VTYX DEADLINE TODAY: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action - VTYX
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal
DEADLINE TODAY: The Schall Law Firm Encourages Investors in Ventyx Biosciences, Inc. with Losses to Contact the Firm
From Schall Law
Via GlobeNewswire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ventyx Biosciences, Inc. (VTYX)
From The Law Offices of Frank R. Cruz
Via Business Wire
VTYX DEADLINE TOMORROW: TOP RANKED ROSEN LAW FIRM Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action - VTYX
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
VTYX DEADLINE TOMORROW: TOP RANKED ROSEN LAW FIRM Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action - VTYX
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal
VTYX DEADLINE: TOP RANKED ROSEN LAW FIRM Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action - VTYX
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
VTYX DEADLINE: TOP RANKED ROSEN LAW FIRM Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action - VTYX
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal
VTYX DEADLINE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action – VTYX
From The Rosen Law Firm PA
Via GlobeNewswire
VTYX DEADLINE ALERT: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action - VTYX
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
VTYX DEADLINE ALERT: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action - VTYX
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal

Frequently Asked Questions

Is Ventyx Biosciences, Inc. - Common Stock publicly traded?
Yes, Ventyx Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Ventyx Biosciences, Inc. - Common Stock trade on?
Ventyx Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Ventyx Biosciences, Inc. - Common Stock?
The ticker symbol for Ventyx Biosciences, Inc. - Common Stock is VTYX on the Nasdaq Stock Market
What is the current price of Ventyx Biosciences, Inc. - Common Stock?
The current price of Ventyx Biosciences, Inc. - Common Stock is 0.8901
When was Ventyx Biosciences, Inc. - Common Stock last traded?
The last trade of Ventyx Biosciences, Inc. - Common Stock was at 04/08/25 10:48 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.